Table of Contents

1 Report Overview

• 1.1 Study Scope
• 1.2 Key Market Segments
• 1.3 Players Covered
• 1.4 Market Analysis by Type
  • 1.4.1 Global Metagenomics in Healthcare Market Size Growth Rate by Type (2014-2025)
  • 1.4.2 Sample Extraction Kits
  • 1.4.3 Metagenomics Kits
• 1.5 Market by Application
  • 1.5.1 Global Metagenomics in Healthcare Market Share by Application (2014-2025)
  • 1.5.2 Pharmaceutical Industries
  • 1.5.3 Biotechnology Companies
  • 1.5.4 Pathology Laboratories
  • 1.5.5 Academic and Research Laboratories
  • 1.5.6 Others
• 1.6 Study Objectives
• 1.7 Years Considered

2 Global Growth Trends

• 2.1 Metagenomics in Healthcare Market Size
• 2.2 Metagenomics in Healthcare Growth Trends by Regions
  • 2.2.1 Metagenomics in Healthcare Market Size by Regions (2014-2025)
  • 2.2.2 Metagenomics in Healthcare Market Share by Regions (2014-2019)
• 2.3 Industry Trends
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Opportunities

3 Market Share by Key Players

• 3.1 Metagenomics in Healthcare Market Size by Manufacturers
  • 3.1.1 Global Metagenomics in Healthcare Revenue by Manufacturers (2014-2019)
  • 3.1.2 Global Metagenomics in Healthcare Revenue Market Share by Manufacturers (2014-2019)
  • 3.1.3 Global Metagenomics in Healthcare Market Concentration Ratio (CR5 and HHI)
• 3.2 Metagenomics in Healthcare Key Players Head office and Area Served
• 3.3 Key Players Metagenomics in Healthcare Product/Solution/Service
• 3.4 Date of Enter into Metagenomics in Healthcare Market
• 3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application

• 4.1 Global Metagenomics in Healthcare Market Size by Type (2014-2019)
• 4.2 Global Metagenomics in Healthcare Market Size by Application (2014-2019)

5 United States

• 5.1 United States Metagenomics in Healthcare Market Size (2014-2019)
• 5.2 Metagenomics in Healthcare Key Players in United States
• 5.3 United States Metagenomics in Healthcare Market Size by Type
• 5.4 United States Metagenomics in Healthcare Market Size by Application

6 Europe

• 6.1 Europe Metagenomics in Healthcare Market Size (2014-2019)
• 6.2 Metagenomics in Healthcare Key Players in Europe
• 6.3 Europe Metagenomics in Healthcare Market Size by Type
• 6.4 Europe Metagenomics in Healthcare Market Size by Application

7 China

• 7.1 China Metagenomics in Healthcare Market Size (2014-2019)
• 7.2 Metagenomics in Healthcare Key Players in China
• 7.3 China Metagenomics in Healthcare Market Size by Type
• 7.4 China Metagenomics in Healthcare Market Size by Application

8 Japan

• 8.1 Japan Metagenomics in Healthcare Market Size (2014-2019)
• 8.2 Metagenomics in Healthcare Key Players in Japan
• 8.3 Japan Metagenomics in Healthcare Market Size by Type
• 8.4 Japan Metagenomics in Healthcare Market Size by Application

9 Southeast Asia

• 9.1 Southeast Asia Metagenomics in Healthcare Market Size (2014-2019)
• 9.2 Metagenomics in Healthcare Key Players in Southeast Asia
• 9.3 Southeast Asia Metagenomics in Healthcare Market Size by Type
• 9.4 Southeast Asia Metagenomics in Healthcare Market Size by Application

10 India

• 10.1 India Metagenomics in Healthcare Market Size (2014-2019)
• 10.2 Metagenomics in Healthcare Key Players in India
• 10.3 India Metagenomics in Healthcare Market Size by Type
• 10.4 India Metagenomics in Healthcare Market Size by Application

11 Central & South America

• 11.1 Central & South America Metagenomics in Healthcare Market Size (2014-2019)
• 11.2 Metagenomics in Healthcare Key Players in Central & South America
• 11.3 Central & South America Metagenomics in Healthcare Market Size by Type
• 11.4 Central & South America Metagenomics in Healthcare Market Size by Application

12 International Players Profiles

• 12.1 Illumina
  • 12.1.1 Illumina Company Details
  • 12.1.2 Company Description and Business Overview
  • 12.1.3 Metagenomics in Healthcare Introduction
  • 12.1.4 Illumina Revenue in Metagenomics in Healthcare Business (2014-2019)
  • 12.1.5 Illumina Recent Development
• 12.2 QIAGEN
  • 12.2.1 QIAGEN Company Details
  • 12.2.2 Company Description and Business Overview
  • 12.2.3 Metagenomics in Healthcare Introduction
  • 12.2.4 QIAGEN Revenue in Metagenomics in Healthcare Business (2014-2019)
  • 12.2.5 QIAGEN Recent Development
• 12.3 PerkinElmer
  • 12.3.1 PerkinElmer Company Details
  • 12.3.2 Company Description and Business Overview
  • 12.3.3 Metagenomics in Healthcare Introduction
  • 12.3.4 PerkinElmer Revenue in Metagenomics in Healthcare Business (2014-2019)
  • 12.3.5 PerkinElmer Recent Development
• 12.4 Thermo Fisher Scientific
  • 12.4.1 Thermo Fisher Scientific Company Details
  • 12.4.2 Company Description and Business Overview
  • 12.4.3 Metagenomics in Healthcare Introduction
  • 12.4.4 Thermo Fisher Scientific Revenue in Metagenomics in Healthcare Business (2014-2019)
  • 12.4.5 Thermo Fisher Scientific Recent Development
• 12.5 Oxford Nanopore Technologies
  • 12.5.1 Oxford Nanopore Technologies Company Details
  • 12.5.2 Company Description and Business Overview
  • 12.5.3 Metagenomics in Healthcare Introduction
  • 12.5.4 Oxford Nanopore Technologies Revenue in Metagenomics in Healthcare Business (2014-2019)
  • 12.5.5 Oxford Nanopore Technologies Recent Development

13 Market Forecast 2019-2025

• 13.1 Market Size Forecast by Regions
• 13.2 United States
• 13.3 Europe
• 13.4 China
• 13.5 Japan
• 13.6 Southeast Asia
• 13.7 India
• 13.8 Central & South America
• 13.9 Market Size Forecast by Product (2019-2025)
• 13.10 Market Size Forecast by Application (2019-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
    • 15.1.1.1 Research Programs/Design
    • 15.1.1.2 Market Size Estimation
    • 12.1.1.3 Market Breakdown and Data Triangulation
  • 15.1.2 Data Source
    • 15.1.2.1 Secondary Sources
    • 15.1.2.2 Primary Sources
• 15.2 Disclaimer

Metagenomics is the study of genetic material recovered directly from environmental samples.
In 2018, the global Metagenomics in Healthcare market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Metagenomics in Healthcare status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Metagenomics in Healthcare development in United States, Europe and China.

The key players covered in this study
Illumina
QIAGEN
PerkinElmer
Thermo Fisher Scientific
Oxford Nanopore Technologies
...

Market segment by Type, the product can be split into
Sample Extraction Kits
Metagenomics Kits

Market segment by Application, split into
Pharmaceutical Industries
Biotechnology Companies
Pathology Laboratories
Academic and Research Laboratories
Others

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Metagenomics in Healthcare status, future forecast, growth opportunity, key market and key players.
To present the Metagenomics in Healthcare development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Metagenomics in Healthcare are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.